martes, 1 de mayo de 2018

Melanoma/Skin Cancer Detection and Prevention Month® (see related guidelines) 1 | National Guideline Clearinghouse 1/1

Search | National Guideline Clearinghouse

ngc

Health Awareness Topics: May 2018

  • GUIDELINE SUMMARY
  •  
  • NGC:010264
  •  
  • 2012 MAR (REVISED 2013 FEB)

Preoperative and pretreatment investigations for malignant melanoma.

  • GUIDELINE SUMMARY
  •  
  • NGC:010262
  •  
  • 2011 FEB (REVISED 2013 FEB)

Optimal excision margins for primary cutaneous melanoma.

  • GUIDELINE SUMMARY
  •  
  • NGC:010672
  •  
  • 1996 (REVISED 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

  • GUIDELINE SUMMARY
  •  
  • NGC:010259
  •  
  • 2010 MAY (REVISED 2013 FEB)

Management of in-transit disease of the limbs.

  • GUIDELINE SUMMARY
  •  
  • NGC:010817
  •  
  • 2015 OCT 7

Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.

  • GUIDELINE SUMMARY
  •  
  • NGC:010248
  •  
  • 2012 MAR (REVISED 2013 FEB)

Biopsy of a suspicious pigmented lesion.

  • GUIDELINE SUMMARY
  •  
  • NGC:010901
  •  
  • 2016 FEB 10

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over.

  • GUIDELINE SUMMARY
  •  
  • NGC:010266
  •  
  • 2011 FEB (REVISED 2013 FEB)

Referral and follow-up surveillance of cutaneous melanoma.

  • GUIDELINE SUMMARY
  •  
  • NGC:010260
  •  
  • 2010 MAY (REVISED 2013 FEB)

Management of resectable stage IV primary cutaneous melanoma without nodal disease.

  • GUIDELINE SUMMARY
  •  
  • NGC:010571
  •  
  • 2014 OCT

Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma.

  • GUIDELINE SUMMARY
  •  
  • NGC:010828
  •  
  • 2015 NOV 11

VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions.

  • GUIDELINE SUMMARY
  •  
  • NGC:010783
  •  
  • 2015 JUL 29

Melanoma: assessment and management.

  • GUIDELINE SUMMARY
  •  
  • NGC:009838
  •  
  • 2013 MAR

Proton beam radiation therapy.

  • GUIDELINE SUMMARY
  •  
  • NGC:011023
  •  
  • 2016 JUL

Final recommendation statement: skin cancer: screening.

  • GUIDELINE SUMMARY
  •  
  • NGC:010882
  •  
  • 2015 AUG

Systemic therapy for unresectable stage III or metastatic cutaneous melanoma.

  • GUIDELINE SUMMARY
  •  
  • NGC:010860
  •  
  • 2015 NOV 25

Pembrolizumab for advanced melanoma not previously treated with ipilimumab.

  • EXPERT COMMENTARY
  •  

Importance of Quality Metrics for Providing High Quality Melanoma Care

  • GUIDELINE SUMMARY
  •  
  • NGC:010377
  •  
  • 2014 FEB

Adjuvant interferon for malignant melanoma.

No hay comentarios:

Publicar un comentario